Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Impaired Liver Function”

410 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 410 results

Very early researchUnknownNCT03673215
What this trial is testing

The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment

Who this might be right for
Liver Cirrhosis
Shenyang Sunshine Pharmaceutical Co., LTD. 58
Early research (Phase 1)Study completedNCT02536911
What this trial is testing

The Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

Who this might be right for
Gaucher Disease
Genzyme, a Sanofi Company 24
Early research (Phase 1)Study completedNCT01919125
What this trial is testing

Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 36
Not applicableStudy completedNCT00305591
What this trial is testing

Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.

Who this might be right for
CirrhosisHepatic Encephalopathy
Imperial College London 50
Early research (Phase 1)Study completedNCT06106113
What this trial is testing

Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Liver Function

Who this might be right for
COVID-19 Pneumonia
Fujian Akeylink Biotechnology Co., Ltd. 24
Early research (Phase 1)Looking for participantsNCT06376474
What this trial is testing

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

Who this might be right for
Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd 24
Early research (Phase 1)UnknownNCT00935454
What this trial is testing

Hepatocyte Matrix Implant Study

Who this might be right for
Liver DiseaseLiver Cirrhosis
Baermed 10
Early research (Phase 1)Looking for participantsNCT06952634
What this trial is testing

An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage

Who this might be right for
Hepatic Impairment
Alumis Inc 48
Early research (Phase 1)Looking for participantsNCT06740799
What this trial is testing

Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment

Who this might be right for
Hepatic Impairment
Daiichi Sankyo 12
Early research (Phase 1)Study completedNCT02894385
What this trial is testing

Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

Who this might be right for
PharmacokineticsHepatic InsufficiencyRenal Insufficiency
Bayer 29
Not applicableStudy completedNCT02010034
What this trial is testing

Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury

Who this might be right for
Liver DiseaseImpaired Liver FunctionParenteral Nutrition Associated Liver Disease
Children's Medical Center Dallas 15
Early research (Phase 1)Study completedNCT01367522
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function

Who this might be right for
Liver Dysfunction
Bausch Health Americas, Inc. 24
Early research (Phase 1)Study completedNCT01027169
What this trial is testing

Assess the Effect of Hepatic Impairment on Safinamide Pharmacokinetics

Who this might be right for
Hepatic Impairment
Newron Pharmaceuticals SPA 24
Early research (Phase 1)Study completedNCT01392807
What this trial is testing

Open-label Study to Assess the Pharmacokinetics of NKTR-118 in Patients With Impaired Hepatic Function

Who this might be right for
Hepatic; Functional Disturbance
AstraZeneca 24
Early research (Phase 1)Study completedNCT00812305
What this trial is testing

Hepatic Impairment Study: Pharmacokinetics in Healthy and Hepatically Impaired Subjects

Who this might be right for
PainHepatic Impairment
Pacira Pharmaceuticals, Inc 16
Not applicableStudy completedNCT01490203
What this trial is testing

Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma

Who this might be right for
Carcinoma, HepatocellularLiver Dysfunction
Seoul National University Hospital 71
Not applicableUnknownNCT02893657
What this trial is testing

The Role and Dynamics of Liver Dysfunction in Patients Undergoing Cardiac Surgery

Who this might be right for
Cardiac SurgeryHepatic ImpairmentHeart Failure
Semmelweis University Heart and Vascular Center 150
Not applicableUnknownNCT03767803
What this trial is testing

Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women

Who this might be right for
Pre-EclampsiaHypertensionProteinuria in Pregnancy+6 more
Progenity, Inc. 344
Early research (Phase 1)Study completedNCT01762462
What this trial is testing

Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Bristol-Myers Squibb 17
Early research (Phase 1)Looking for participantsNCT06908954
What this trial is testing

The Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy Adult Participants After Intake of a Single Dose

Who this might be right for
Hepatic ImpairmentHealthy
Ipsen 32
Load More Results